Market Cap (In USD)
9.88 Million
Revenue (In USD)
98 Thousand
Net Income (In USD)
-3.48 Million
Avg. Volume
9298.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.064-0.23
- PE
- -
- EPS
- -
- Beta Value
- 0.502
- ISIN
- US40171F5017
- CUSIP
- 40171F501
- CIK
- 924515
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Dr. Mark L. Faupel Ph.D.
- Employee Count
- -
- Website
- https://www.guidedinc.com
- Ipo Date
- 2021-01-08
- Details
- Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
More Stocks
-
NLY-PF
-
GOGL
-
028300HLB Co., Ltd.
028300
-
SGBAFSES S.A.
SGBAF
-
002862
-
KALAMANDIRSai Silks (Kalamandir) Limited
KALAMANDIR
-
004370Nongshim Co., Ltd.
004370
-
BIONBB Biotech AG
BION